Abattis Names New CFO, COO

Publicly traded Canadian MMJ company Abattis Bioceuticals Corp. has named real estate and finance veteran Rene David to the posts of chief financial officer and chief operating officer.

The move comes as Abattis prepares for rapid growth amid drastic changes in the Canadian medical marijuana industry. The country has opened up its MMJ program to the free market, a move that’s expected to increase the patient base exponentially and create more than $1 billion in medical cannabis sales. Abattis also has its sights set on the adult-use market in the United States.

Abattis said David enhances the company’s knowledge of structured funding and that he will help put in place better internal financial controls and implement related best practices. He will focus on those areas as well as analysis, procurement and contract management.

David has a varied professional background, having worked at Canada’s largest credit union and in the fields of investment banking, real estate development and the natural resources, food and water industries.

Abattis (ticker symbol ATTBF on the OTC market) provides services and products to the cannabis industry, including growing systems and extraction equipment.

 

 

Leave a Reply

Your email address will not be published. Required fields are marked *